INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Unicycive Therapeutics, Inc. to Contact Law Firm

Article summary

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shareholders should email fletcher@fmoorelaw.com NEW YORK, Oct. 20, 2026 — What is the Investigation About? On June 30, 2026, before the market opened, Unicycive disclosed that the FDA had issued a second Complete Response Letter...